FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:152-153 July 12, 2001 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Jonathan A. Ledermann, William J. Hoskins, Stanley B. Kaye, and Ignace B. Vergote. 298 pp., illustrated. London, Martin Dunitz, 2001. $125. ISBN 1-85317-704-0.

Epithelial ovarian cancer, the second most common cancer of the female genital tract, accounts for 5 percent of cancers in women. In the United States this year, 23,400 new cases will be diagnosed, and 13,900 women afflicted with the disease will die. The five-year survival rate is 50 percent overall, 95 percent in patients with localized disease, 79 percent in those with regional disease, and 28 percent in those with distant disease. Clinical Management of Ovarian Cancer synthesizes the extensive literature in order to outline systematically the evaluation and treatment of ovarian cancer. Topics are discussed in the context of . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.